The popular Chinese consumer healthcare platform's business has covered 80% of high-end dental chain organizations.
On June 23, 2021, Linkedcare, a popular Chinese consumer healthcare platform, has completed its round D financing, which is led by Investcorp and followed by Jinding Capital and Shengye Capital. The company has raised over USD 100 million in two series financing, series C2 and series D, in the past six months.
Founded in 2015, the company's primary business is to provide SaaS management software for medical-related institutions. It provides solutions including chain store management, customer relationship management, in- & out-patient management, and even business intelligence analysis, which meet all consumer healthcare needs. After six years of development, Linkedcare is providing SaaS management software for more than 30,000 dental and cosmetic medicine institutions, covering 80% of high-end dental chain organizations.
The Linkedcare team pointed out that the current consumer medical SaaS market still has significant growth potential. For example, the CAGR of the dental industry reaches 16%, while the CAGR of the medical and aesthetic industry also exceeds 15%. At the same time, the upstream consumer healthcare industry competition is fierce, and they are optimistic about the online platform, which brings the long-term potential to Chinese one-stop media like Linkedcare.